Invention Grant
- Patent Title: Anti-human CTGF antibody
- Patent Title (中): 抗人CTGF抗体
-
Application No.: US14367081Application Date: 2012-12-21
-
Publication No.: US09587015B2Publication Date: 2017-03-07
- Inventor: Shoji Iwasaki , Ryuichi Moriya , Masayasu Yoshino , Koji Takakura
- Applicant: ASTELLAS PHARMA INC.
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2011-281811 20111222
- International Application: PCT/JP2012/083206 WO 20121221
- International Announcement: WO2013/094723 WO 20130627
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C12P21/06 ; C12P21/04 ; C12N15/00 ; C12N5/00 ; C07K16/00 ; C07H21/00 ; C07K16/22 ; C07K14/475 ; A61K39/00
Abstract:
Novel anti-human CTGF antibodies having excellent binding activity and/or neutralizing activity, as compared with conventional anti-human CTGF antibodies, are useful for treating various diseases in which human CTGF is involved in pathogenesis, including renal diseases such as chronic kidney disease and diabetic nephropathy.
Public/Granted literature
- US20140343258A1 NOVEL ANTI-HUMAN CTGF ANTIBODY Public/Granted day:2014-11-20
Information query
